Clinical Psychiatry NewsU.S. overdose deaths hit an all-time highNovember 18, 2021Addiction MedicineOpioid Resource CenterPain
Clinical Psychiatry NewsBiden seeks to return Califf as FDA chiefNovember 15, 2021Business of Medicine
Clinical Psychiatry NewsFDA stands firm on deadline for clozapine REMS recertificationNovember 13, 2021Schizophrenia & Other Psychotic Disorders
Clinical Psychiatry NewsFDA panel votes to approve Pfizer’s vaccine for childrenOctober 26, 2021COVID-19 UpdatesPediatrics
Clinical Psychiatry NewsPandemic drives uptick in need for mental health servicesOctober 22, 2021DepressionAnxiety DisordersMajor Depressive Disorder
Clinical Psychiatry NewsFDA clears 5-minute test for early dementiaOctober 21, 2021GeriatricsNeurologyAlzheimer's & Cognition
Clinical Psychiatry NewsFDA authorizes boosters for Moderna, J&J, allows mix-and-matchOctober 20, 2021COVID-19 Updates
Clinical Psychiatry NewsFDA OKs new high-dose naloxone product for opioid overdoseOctober 19, 2021Addiction MedicinePain
Clinical Psychiatry NewsFDA panel backs second dose for Johnson & Johnson vaccine recipientsOctober 15, 2021COVID-19 Updates
Clinical Psychiatry NewsFDA advisors vote to recommend Moderna boostersOctober 14, 2021COVID-19 Updates
Clinical Psychiatry News‘Impressive’ results for novel antidepressant, so why the FDA delay?October 14, 2021DepressionMajor Depressive Disorder
Clinical Psychiatry NewsJohnson & Johnson requests FDA approval for vaccine booster dosesOctober 5, 2021COVID-19 Updates
Clinical Psychiatry NewsFDA okays new oral CGRP antagonist for migraine preventionSeptember 29, 2021PainNeurology
Clinical Psychiatry NewsCDC chief overrules panel, OKs boosters for health care workersSeptember 24, 2021COVID-19 Updates
Clinical Psychiatry NewsFDA inaction on hair loss drug’s suicide, depression, erectile dysfunction risk sparks lawsuitSeptember 9, 2021Depression
